Part 2: Implementing Clinical Trials: A Review of the Attributes of Exemplary Clinical Trial Sites

被引:7
|
作者
Zon, Robin [1 ]
Cohen, Gary [2 ]
Smith, Dee Anna [3 ]
Baer, Allison R. [4 ]
机构
[1] Northern Indiana Canc Res Consortium, Michiana Hematol Oncol, South Bend, IN USA
[2] Greater Baltimore Med Ctr, Berman Canc Inst, Baltimore, MD USA
[3] Sarah Cannon Res Inst, Nashville, TN USA
[4] Amer Soc Clin Oncol, Alexandria, VA USA
关键词
D O I
10.1200/JOP.2010.000185
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This two-part article was developed on the basis of an education session at the 2010 ASCO Annual Meeting and aims to provide practical advice to investigators and their teams who want to implement one, or all, of the attributes of exemplary clinical trial sites. These voluntary attributes were developed by ASCO in 2008 to provide guidance to investigators who want to exceed the good clinical practice guidelines. ASCOrecognizes that research sites that want to implement the exemplary attributes may be limited by insufficient resources. Acknowledging this challenge, the ASCO Cancer Foundation has developed grant and award opportunities related to the exemplary attributes. More information about these opportunities is available online at http://www.ascocancerfoundation.org/. ASCO has also developed aWeb page to provide sites with additional educational resources related to the practice of clinical research: www.asco.org/ clinicaltrialresources. New to this page are free, online videos recorded by experts in the field of clinical research. Copyright © 2011 by American Society of Clinical Oncology.
引用
收藏
页码:61 / 64
页数:4
相关论文
共 50 条
  • [1] Implementing Clinical Trials: A Review of the Attributes of Exemplary Clinical Trial Sites
    Baer, Allison R.
    Cohen, Gary
    Smith, Dee Anna
    Zon, Robin
    [J]. JOURNAL OF ONCOLOGY PRACTICE, 2010, 6 (06) : 328 - 330
  • [2] American society of clinical oncology statement on minimum standards and exemplary attributes of clinical trial sites
    Zon, Robin
    Meropol, Neal J.
    Catalano, Robert B.
    Schilsky, Richard L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15) : 2562 - 2567
  • [3] CONSIDERATIONS REGARDING THE QUALIFICATION OF CLINICAL TRIAL SITES AND INVESTIGATORS IN CLINICAL TRIALS WITH ATMPS
    Hildebrandt, M.
    [J]. CYTOTHERAPY, 2019, 21 (05) : S45 - S45
  • [4] Clinical Trials Without Clinical Sites
    Cummings, Steven R.
    [J]. JAMA INTERNAL MEDICINE, 2021, 181 (05) : 680 - 684
  • [5] Risk Management in Clinical Trials: Assessment of Current Practices at Portuguese Clinical Trial Sites
    Vale, Margarida
    Leite, Francisca
    Madeira, Catarina
    [J]. RISK MANAGEMENT AND HEALTHCARE POLICY, 2023, 16 : 2187 - 2196
  • [6] Statistical Controversies in Reporting of Clinical Trials Part 2 of a 4-Part Series on Statistics for Clinical Trials
    Pocock, Stuart J.
    McMurray, John J. V.
    Collier, Tim J.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (23) : 2648 - 2662
  • [7] Clinical trials in ovarian cancer, Part 2
    Trimble, EL
    Schoenfeldt, M
    Cornelison, TL
    Wright, J
    Kolker, A
    Christian, M
    [J]. ONCOLOGY-NEW YORK, 2002, 16 (12): : 1660 - +
  • [8] Challenging Issues in Clinical Trial Design Part 4 of a 4-Part Series on Statistics for Clinical Trials
    Pocock, Stuart J.
    Clayton, Tim C.
    Stone, Gregg W.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (25) : 2886 - 2898
  • [9] CLINICAL TRIALS ON TRIAL
    不详
    [J]. LANCET, 1967, 2 (7515): : 553 - &
  • [10] Clinical trials on trial
    Vulto, Arnold G.
    [J]. EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE, 2012, 19 (04): : 347 - 347